Seratrodast

From WikiMD's WELLNESSPEDIA

Chemical structure of Seratrodast

Seratrodast is a thromboxane receptor antagonist used primarily in the management of asthma. It functions by inhibiting the action of thromboxane A2, a compound that contributes to bronchoconstriction and inflammation in the airways. By blocking this receptor, seratrodast helps to alleviate the symptoms associated with asthma, such as wheezing and shortness of breath.

Pharmacology[edit]

Seratrodast is classified as a thromboxane receptor antagonist. Thromboxane A2 is a potent vasoconstrictor and pro-inflammatory mediator that plays a significant role in the pathophysiology of asthma. By antagonizing the thromboxane receptor, seratrodast reduces bronchoconstriction and inflammation, leading to improved airflow and reduced asthma symptoms.

Mechanism of Action[edit]

The primary mechanism of action of seratrodast involves the selective inhibition of the thromboxane A2 receptor. This inhibition prevents thromboxane A2 from binding to its receptor, thereby reducing the downstream effects of bronchoconstriction and inflammation. This action helps to maintain open airways and improve respiratory function in patients with asthma.

Clinical Use[edit]

Seratrodast is used in the treatment of asthma, particularly in patients who do not respond adequately to standard therapies such as inhaled corticosteroids and beta-agonists. It is often used as an adjunctive therapy to help control asthma symptoms and improve overall lung function.

Side Effects[edit]

Common side effects of seratrodast may include headache, dizziness, and gastrointestinal disturbances such as nausea and diarrhea. As with any medication, there is also the potential for allergic reactions, which should be monitored closely.

Synthesis[edit]

Synthesis of Seratrodast

The synthesis of seratrodast involves several chemical reactions, starting from basic organic compounds. The process includes the formation of key intermediates that are subsequently modified to produce the final active pharmaceutical ingredient. The detailed steps of the synthesis are crucial for ensuring the purity and efficacy of the drug.

Related Pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.